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AbstrACt 
Introduction Acute hospital admission is distressing 
for care home residents. Ambulatory care sensitive 
conditions, such as respiratory and urinary tract infections, 
are conditions that can cause unplanned hospital 
admission but may have been avoidable with timely 
detection and intervention in the community. The Better 
Health in Residents in Care Homes (BHiRCH) programme 
has feasibility tested and will pilot a multicomponent 
intervention to reduce these avoidable hospital admissions. 
The BHiRCH intervention comprises an early warning tool 
for noting changes in resident health, a care pathway 
(clinical guidance and decision support system) and 
a structured method for communicating with primary 
care, adapted for use in the care home. We use practice 
development champions to support implementation and 
embed changes in care.
Methods and analysis Cluster randomised pilot trial 
to test study procedures and indicate whether a further 
definitive trial is warranted. Fourteen care homes with 
nursing (nursing homes) will be randomly allocated to 
intervention (delivered at nursing home level) or control 
groups. Two nurses from each home become Practice 
Development Champions trained to implement the 
intervention, supported by a practice development support 
group. Data will be collected for 3 months preintervention, 
monthly during the 12-month intervention and 1 month 
after. Individual-level data includes resident, care partner 
and staff demographics, resident functional status, service 
use and quality of life (for health economic analysis) 
and the extent to which staff perceive the organisation 
supports person centred care. System-level data includes 
primary and secondary health services contacts (ie, 
general practitioner and hospital admissions). Process 
evaluation assesses intervention acceptability, feasibility, 
fidelity, ease of implementation in practice and study 
procedures (ie, consent and recruitment rates).
Ethics and dissemination Approved by Research Ethics 
Committee and the UK Health Research Authority. Findings 
will be disseminated via academic and policy conferences, 
peer-reviewed publications and social media (eg, Twitter).
trial registration number ISRCTN74109734; Pre-results.
IntroduCtIon
background
Currently in the UK 421 100 people aged over 
65 years live in residential care, including 
care homes with nursing (referred to subse-
quently in this paper as ‘nursing homes’).1 
Older people living in nursing homes have 
increasing levels of comorbidity,2–4 frailty 
and physical health needs.5Ambulatory care 
sensitive conditions (ACSCs) are ‘condi-
tions that can lead to unplanned hospital 
strengths and limitations of this study
 ► We are testing a complex intervention that has been 
developed to reduce avoidable acute hospital ad-
missions in nursing home residents. The interven-
tion has been developed in collaboration with key 
stakeholders, taking into account the complexities 
of implementing enhanced practice in this setting.
 ► A strength of the intervention is that implementa-
tion is led in the care home by Practice Development 
Champions, supported by practice development 
support group.
 ► We will assess feasibility of recruitment and out-
come data collection at individual and system level 
and also consider how well the intervention was im-
plemented in practice.
 ► This is a pilot study that will indicate whether a fur-
ther study is warranted but will not give data on the 
effectiveness of the intervention.
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admissions that may been have avoidable or manageable 
by timely access to medical care in the community’.6 The 
conditions include: angina, asthma, cellulitis, chronic 
obstructive pulmonary disease, congestive heart failure, 
dehydration, diabetes mellitus, gastroenteritis, epilepsy, 
hypertension, hypoglycaemia, urinary tract infec-
tions (UTI), pneumonia, severe ear, nose and throat 
infections.7 
In the UK, ACSCs account for one-sixth of hospital 
admissions from all age groups.8 Our ageing popu-
lation led to a 40% increase in admissions between 
2001 and 2011,9 and all-cause hospital admissions from 
nursing homes rose by 63% between 2011 and 2015.10 
Four ACSCs contribute to a large proportion of hospital-
isations from nursing homes: respiratory infections,11–14 
acute exacerbation of chronic heart failure,15 16 UTIs13 17 
and dehydration,13 and may underlie other problems such 
as falls and delirium.
In addition to causing distress to residents, their fami-
lies and staff, hospitalisation is expensive for health and 
social care systems. Hospital admission increases the risk 
of decline in functional ability, delirium, adverse events 
and prolonged stays.18 19 Areas with many nursing homes 
tend to have higher rates of unplanned hospital admis-
sion in the over-75 age group.20 The King’s Fund8 and 
British Geriatrics Society2 have raised concerns about the 
quality of healthcare provision to nursing homes. The 
UK National Health Service (NHS)21 has made reducing 
avoidable hospital admission from nursing homes a policy 
imperative.
A number of interventions have been developed, 
falling broadly into two categories; multicomponent 
interventions (implementation of a range of tools) and 
single-component interventions (predominantly advance 
care planning or single disease care pathways (eg, pneu-
monia). Multicomponent interventions show significant 
reductions in avoidable admissions.22–26 Key characteris-
tics include enhancing knowledge and skills of nursing 
home staff,27 clinical guidance and decision-support tools 
(care pathways), engaging with families28 and specialist 
input from geriatricians or nurse practitioners.22 In addi-
tion, research highlights the importance of collaborative 
development of interventions with nursing home staff,29 
residents and families,28 considering implementation 
support16 and using local champions.
The intervention with the strongest evidence base is 
‘INTERACT’ (Interventions to Reduce Acute Care Trans-
fers). This complex intervention, developed and imple-
mented in the USA, aims to detect and diagnose a range 
of medical conditions in residents recently discharged 
from hospital to skilled nursing facilities and reduce read-
missions. It comprises a quality improvement programme 
focusing on the management of acute changes in resi-
dents’ condition16:
 ► Communication tools, for example, Stop and Watch 
early warning tool and Situation Background Assess-
ment Response (SBAR) structured communication 
with primary care tool.
 ► Care pathways or clinical tools addressing, for 
example, dehydration, UTI, fever and acute mental 
status change.
 ► Advanced care planning, tracking and communica-
tion tools.
Intervention development
In the preliminary stages of the Better Health in Resi-
dents in Care Homes (BHiRCH) programme, we worked 
with stakeholders including staff and our carer reference 
panel (CRP), to develop and adapt the INTERACT tools 
for use in the UK (Blighe et al, unpublished data, 2018). 
We identified current UK care pathways for ACSCs in 
nursing homes for our four key conditions (respiratory 
infections, acute exacerbation of chronic heart failure, 
UTIs and dehydration) and adapted them in consensus 
co-design workshops with staff and care partners.
We conducted a rapid research review and semistruc-
tured interviews to understand the optimal approach 
to enhance skills and knowledge in nursing home staff. 
The Promoting Action on Research Implementation 
in Health Services (PARiHS) framework was used to 
co-design implementation support and guidance.30 We 
conducted a feasibility and acceptability study in two 
nursing homes in the north of England between October 
2016 and January 2017 to optimise the intervention and 
its implementation.
Aim and objectives
The aim of this pilot trial is to indicate whether a defini-
tive study is warranted.
Primary objective
Indicate whether the intervention is acceptable and 
feasible.
Secondary objectives
1. Establish whether consent procedures facilitate collec-
tion of sufficient individual-level data.
2. Assess the effectiveness of the implementation strategy.
3. Assess intervention fidelity.
4. Assess level of nursing home staff engagement with the 
intervention.
5. Explore whether the intervention would be sustain-
able outside the trial context.
6. Measure completeness of data collection, documenta-
tion, return rate of questionnaires and assess potential 
primary and secondary outcomes for a definitive trial.
7. Assess feasibility of collecting data for economic 
evaluation.
MEthods And AnAlysIs
trial design
A pilot cluster randomised trial in nursing homes with 
process evaluation. The intervention aims to deliver 
enhanced ‘usual care’, with specifically developed 
tools that formalise current good practice, delivered by 
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existing staff. The nursing home is the unit of allocation 
and intervention.
study population
Nursing homes
We will recruit 14 nursing homes (eight in West Yorkshire 
and six in London) with adequate staffing to implement 
the intervention and support research activities. Nursing 
homes rated ‘inadequate’ by the Care Quality Commis-
sion (UK body responsible for assuring care quality) 
are ineligible. Nursing homes will be identified via local 
Clinical Research Networks and the Enabling Research 
in Care Homes Network. We will gain written permis-
sion from the manager, regional manager or owner. 
Our intervention will be implemented at nursing home 
level so individual consent is not required to receive the 
intervention.
Individual participants
All English-speaking staff and residents over 65 years and 
their care partners (family members or friends) will be 
invited to participate in the collection of individual level 
data until we have recruited approximately 20 residents 
and staff from each nursing home. Residents receiving 
end-of-life care, who are under 65, non-English speaking 
or have stated they do not wish to be involved in research 
will be excluded. No further data will be collected from 
the care partner if the resident dies during follow-up.
sample size and selection
This is a pilot study to inform the sample size calculation 
for a definitive trial, so no sample size calculation was 
conducted. Nursing homes will be purposively selected 
including a range of providers (large and small chains, 
independent providers), urban, suburban and rural. 
Nursing homes will be randomised prior to interven-
tion; four in West Yorkshire and three in Greater London 
(seven total) to the intervention and four in West York-
shire and three in Greater London (seven total) to ‘usual 
care’ stratified by location, by Priment Clinical Trials Unit 
using a randomisation list drawn up by an independent 
statistician.
Consent procedures
Residents
The care home manager or deputy manager will identify 
all potentially eligible residents. If necessary, the research 
team will conduct a capacity assessment with respect to 
the participation in this trial, adhering to the Mental 
Capacity Act (2005).
If the resident lacks capacity to consent, we will use a 
personal consultee (friend or family), or if none is avail-
able, a professional consultee. This will be a member of 
health or social care staff with a professional relation-
ship to the resident but no connection with the project. 
If a resident loses capacity during the study a consultee 
(either personal or professional) will be found. During 
the study, we will consider ongoing (process) consent, 
checking willingness to participate with the resident or 
consultee.
Care partners and nursing home staff
Care partners associated with residents who have been 
recruited to the study and nursing home staff will be 
asked if they wish to answer questionnaires and/or take 
part in qualitative interviews and give informed consent 
for this.
study procedures
The study will run for 16 months between 1 November 2017 
and 3 March 2019 (see figure 1). Posters will be placed 
in nursing homes and there will be sign-up sheets where 
potential participants can indicate interest. We will 
publicise the project using established communications 
between the nursing home and care partners such as their 
regular newsletters. A ‘launch’ event will be organised in 
each nursing home where the research team, members 
of the CRPs and nursing home staff will explain the study 
and distribute recruitment literature.
Each participating nursing home will appoint a research 
facilitator to support the research team with recruitment 
activities, ensuring nursing home-level data collected 
without consent from the resident are pseudoanonymised 
prior to being given to the research team. The research 
facilitator may be a care home nurse or administrator and 
will be supported by the research assistant allocated to the 
care home. They will not be involved in implementing 
the intervention.
IntErvEntIon
This intervention is delivered by nursing home staff 
trained and supported by Practice Development Cham-
pions (PDCs) nominated from each intervention nursing 
home by its managers, based on a person specification 
Figure 1 Pilot trial flow chart.
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developed from research on facilitating implementation 
of research evidence (box 1). 
Implementation support
PDCs workshop
A 1-day workshop will be delivered for the two PDCs from 
each nursing home by the research team comprising an 
introduction to the four key conditions (respiratory infec-
tions and UTIs, dehydration and acute exacerbation of 
chronic heart failure) and elements of how to bring about 
organisational change. This will focus on: how to estab-
lish and coordinate the practice development support 
group of nursing home staff, care partners and external 
staff (eg, primary care professionals) who can support 
introduction and embedding of the change, strategies 
for engaging people and encouraging continued partic-
ipation and strategies for gathering routinely collected 
data to monitor implementation. They will be given an 
overview of the intervention materials including the 
structured approach to effective communication with 
primary care staff. We will also explore potential changes 
to communication flows and recording of information 
about residents.
Ongoing implementation support
1. PDCs will be supported by a project handbook creat-
ed for staff use. In addition, the Practice Development 
Workbook for Nursing, Health and Social Care Teams: 
Resources for Health and Social Care Teams (Dewing et al, 
2014) will be provided. PDCs can access peer support 
on the study website and monthly telephone support 
from the research team.
2. PDCs will select members of a practice development 
support group to support their work in the nursing 
home. This Quality Collaborative approach31 involves 
diverse stakeholders working together to close the gap 
between actual and potential practice. The group will 
support the PDCs and intervention implementation 
taking into account the context at their site.
3. Monthly support phone call between PDCs and a se-
nior nurse researcher.
the intervention
This commences after recruitment and randomisation. 
There are three key components, all paper based as UK 
care homes have variable use of electronic records:
1. Early Warning Tool (Stop and Watch Early Warning Tool; 
http://www. pathway- interact. com/ wp- content/ up-
loads/ 2017/ 04/ 148604- Stop- and- Watch- v4_ 0. pdf).
2. Care Pathway (clinical guidance and decision support 
system).
3. Structured method for communicating with primary 
care (SBAR).
Stop and Watch Early Warning Tool
Care assistants or nurses will use this when they or anyone 
else in the nursing home (including other staff and care 
partners) notices a change in a resident, at latest by the 
end of the shift. They will circle observed changes, noti-
fying the nurse and giving them the completed tool to be 
placed in the nursing home records.
Care Pathway
This is a two-step clinical guidance and decision support 
system. The initial ‘Primary’ assessment comprises 
screening questions with the potential to trigger a 
more detailed ‘Secondary’ assessment. If the Primary 
or Secondary Assessment result is ambiguous, the Care 
Pathway will be administered at 6 hour intervals, until 
concerns have resolved and/or appropriate intervention 
has been instigated. The nurse will record the outcome of 
the primary and secondary assessment and their care plan 
in the residents’ care records and make a clinical decision 
about the next course of action which may include direct 
further monitoring using the Stop and Watch Early Warning 
Tool, initiating treatment in the nursing home, or if the 
assessment indicates a potential diagnosis or immediate 
concern, communication with primary care using the 
SBAR process. The nurse will feed back on the course of 
action to relevant staff on each shift, domestic staff and 
care partners, as appropriate. Copies of the completed 
Care Pathway will be kept with the resident’s record.
box 1 Practice development Champion person 
specification
The Practice Development Champion will:
 ► Be a registered nurse.
 ► Have been working in the nursing home for at least 6 months.
When selecting a Practice Development Champion, we are looking for 
someone who:
 ► Has some knowledge of good practice in supporting healthcare 
and has an interest in the topic (can demonstrate some essential 
knowledge of the management of the four conditions: chronic heart 
failure, respiratory infections, urinary tract infection, dehydration).
 ► Knows co-workers (has been in the organisation long enough to 
know the staff and how they work).
 ► Knows the environment (has some insight into the culture of the 
setting).
 ► Knows the organisation (knows their way around the organisa-
tion, for example, who’s who, policies in place, decision-making 
structures).
 ► Possesses effective communication skills (could include attributes 
of being open minded, being creative, has experience of managing 
meetings/groups, able to talk in front of groups).
 ► Is self-aware and resilient (has insight into their support needs, but 
is also not afraid of challenge/conflict; willing to engage in own pro-
fessional development).
 ► Is reliable and dependable (has time they can dedicate to this work 
(in writing from their manager); carries through with responsibilities, 
meets deadlines or negotiates otherwise; is not intending to be on 
extended leave during intervention period).
 ► Is respected by co-workers (has a good relationship with co-work-
ers which means they will be listened to with respect to new ideas).
These criteria are ESSENTIAL and are NOT listed in a hierarchy/order of 
importance, that is, they are all equally important.
From Seers et al 2012 FIRE (facilitating implementation of research ev-
idence): a study protocol http://implementationscience.biomedcentral.
com/articles/10.1186/1748-5908-7-25
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The SBAR method
A structured method for communicating critical infor-
mation to primary care. The nurse uses this when they 
want primary care input for one of their residents after 
the Care Pathway indicates a risk of decline. Before calling, 
the nurse will organise the briefing information on paper 
using the four elements (situation, background, assess-
ment and recommendation).
usual care group
Participants in nursing homes randomised to control 
arms will receive usual care according to existing local 
policy and practice. All medications and treatments will 
be permitted.
study measures
We will collect data in three domains: (1) individual level 
data on nursing home residents, their care partners and 
staff; (2) system-level data and (3) process data.
Individual-level data
These will be collected from staff, care partners or resi-
dents who have given informed consent or from residents 
for whom we have obtained agreement from a consultee. 
These data includes resident, care partner and staff demo-
graphics, assessment of resident functional status (Barthel 
index32) and resident service use and quality of life to 
inform health economic analysis (Client Services Receipt 
Inventory33 (CSRI), EQ-5D-5L34). Staff education, role 
and the extent to which they perceive the organisation 
to support person-centred care (Organisational Support 
for Person-centred Care Assessment Tool35) and Nurse 
Ratings of Communication with Primary Care Ques-
tionnaire36 will be gathered to understand the context 
(table 1).
System-level data
These will be collected from the nursing home using 
existing paper or electronic record systems. Data will be 
pseudoanonymised and provided by the nursing home 
manager or research facilitator. We will document the 
total number of contacts with GPs, ambulances, A&E 
visits, deaths, staff turnover and the number of nursing 
home beds available to new residents in the previous 
month, per care home. We will document all hospital 
admissions and select a sample of 30 of these (where we 
have individual consent from a resident to access their 
health records), purposively selected to represent a range 
of underlying ACSCs diagnoses. We will explore the 
‘avoidability’ of these with the Structured Implicit Record 
Review tool.37 This facilitates comparison by two indepen-
dent clinical experts (geriatrician and community nurse) 
of selected content in residents’ nursing home records to 
assess whether the admission was ‘avoidable’.
Process evaluation
We will examine how the intervention is implemented 
in practice, collecting information on the number of 
‘Stop and Watch’ Early Warning Tools completed, who 
noticed the change in the resident’s health status, who 
completed the form, and actions that occurred after the 
form was completed; number of primary and secondary 
assessments, and outcome of assessments including the 
number of residents who underwent further monitoring, 
had their treatment initiated in the nursing home, or 
were referred to primary care. We will monitor interven-
tion fidelity noting where nursing homes make amend-
ments to the structure or content of the care pathway. 
PDCs will have a monthly support phone call with the 
research team to reflect on their activities and achieve-
ments which we will document. They will keep an activity 
log of support provided by practice development support 
groups to document the level of facilitation required to 
support the implementation process. To understand the 
effectiveness of study procedures we will collect data on 
consent and recruitment rates, the numbers of care part-
ners who wish to be involved in the resident’s care, assess 
completeness of outcome measures, data collection and 
return rate of questionnaires.
We will conduct 20 semistructured interviews (30–45 min 
each) with five nursing home managers, five nurses, five 
care assistants and five care partners from the seven 
intervention homes. We will explore participants’ views 
on the effectiveness of the intervention in preventing 
avoidable hospital admissions and their experiences of 
implementing the intervention. Care partners will be 
purposively sampled to ensure a range of gender, age and 
types of family carer. All participants will give informed 
consent, including for recording of their interviews.
data management
All data will be entered onto paper case report forms 
(CRFs) and then into an encrypted password protected 
database in accordance with the UK Data Protection Act 
and General Data Protection Regulation. CRFs will not 
bear the participant’s name but a pseudoanonymised 
identification number. To maintain confidentiality the 
research facilitator will remove the name of the partic-
ipant from completed Stop and Watch Early Warning 
Tool and Care Pathway Primary and Secondary Assess-
ment Forms and replace this with an ID number. Prior to 
analysis we will follow a standardised process for database 
lock.
randomisation
The SAS statistical programme (version 9.4) will be used 
for randomisation. Blinding is not feasible for research 
staff collecting data, but statisticians and health econo-
mists will be blinded to allocation. The randomisation 
variable will be supplied to them unlabelled, and main 
analysis completed using this.
data analysis plan
We shall follow Consolidated Standards of Reporting Trials 
(CONSORT) guidelines for reporting randomised trials. 
Given this is a pilot study, analyses will be mainly descrip-
tive focussing on recruitment, participant characteristics, 
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Table 1 Summary of data collected, outcome measures and time schedule
Data collected and tool used Pre-intervention Monthly
At 6 months 
only Post-intervention
Resident
  Sociodemographics Age, gender, ethnicity, marital status, 
highest level of education.
R – – –
  Service use in the prior 
month
Client Service Receipt Inventory (ref). 
Calculates service and total care 
costs.
R R R R
  Functional status The Barthel Index.32 R – R R
  Resident quality of life-self 
rated
EQ-5D-5L (ref) self-rated health index 
and Visual Analogue Scale of current 
health state.
P – P P
  Resident quality of life-
proxy rated
EQ-5d-Proxy (ref) care partner or staff 
member view of the resident’s quality 
of life.
CP/S – CP/S CP/S
Care partner
  Sociodemographics Age, gender, ethnicity, marital status, 
years of schooling, highest level of 
education.
CP – CP CP
  Quality of life EQ-5D-5L EuroQol (1990). CP – CP CP
  Preferred role How much and how they like to be 
involved in the residents care.
CP – – –
Staff
  Staff sociodemographics Age, gender, ethnicity, number of 
years of education.
R – – –
  Staff work characteristics Highest qualification, role in care 
home, length of service, shift pattern, 
first language.
R – – –
  Organisational support for 
person-centred care
The Person-Centred Care 
Assessment Tool (ref).
S – S S
  Communication with 
primary care
Nurse-General Practitioner 
Communication Needs Assessment 
Questionnaire.
S – S S
  Perceived knowledge and 
skills for early detection in 
changes in health
Developed from feasibility study. 
Assesses key knowledge and skills 
needed to implement the intervention. 
Rated on 5-point Likert scale; 1 
(disagree completely) to 5 (agree 
completely).
S – S S
System-level data
  Number of hospital 
admissions
Respiratory infections, urinary tract 
infections, dehydration, congestive 
heart failure?
S S S S
  ‘Avoidability’ of admissions Structured Implicit Record Review.
Saliba et al, 2000
S S S S
  Use of primary assessment 
tool
Respiratory infections, urinary tract 
infections, dehydration, congestive 
heart failure?
S S S S
  Use of secondary 
assessment tool
Respiratory infections, urinary tract 
infections, dehydration, congestive 
heart failure?
S S S S
  Out of hours GP contacts GP visits or telephone contact. S S S S
  Ambulances and hospital 
use
Number and length of hospital 
admissions (days), accident and 
emergency attendances and 
readmissions.
S S S S
Continued
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other baseline and outcome variables, loss to follow-up 
and tabulation of serious adverse events (SAEs). We shall 
compare rates of hospital admission for ACSCs and other 
outcomes between the control and intervention groups 
and calculate 95% CIs. These, along with estimates of 
SD of other outcome measures and intraclass correla-
tion coefficients will inform the sample size calculation 
for a full trial. We will summarise completeness of data 
collection on outcome measures and, for questionnaires, 
describe distributions and response rates.
Economic evaluation
Analyses will conform to accepted economic evaluation 
methods (National Institute for Health and Care Excel-
lence, 2008). We will calculate costs associated with the 
intervention, including the cost of enhancing staff’s 
knowledge and skills and resources associated with imple-
mentation. Resource use associated with hospital admis-
sions, primary care and other NHS and social care costs 
will be collected using the CSRI. Costs will be reported 
from an NHS/prescribed specialised services (PSS), 
government and societal perspective. We will assess feasi-
bility of calculating quality-adjusted life years (QALYs) for 
residents, using the EQ-5D- 5 L. In the societal level anal-
ysis, a calculation of carers’ QALYs will be included. We 
will provide an initial estimate of the incremental mean 
cost per QALY gained in intervention compared with 
control homes. Cost-effectiveness acceptability curves, 
showing the percentage of cases that the intervention is 
cost-effective over a range of values of willingness to pay 
for a QALY gained, will be constructed for each different 
costing perspective and for the different methods of 
calculating QALYs. We will model the lifetime costs and 
outcomes of the intervention compared with controls. 
This will involve assessing the quality of the published 
information available, the development of an initial 
model and identification of which cost and outcome 
components would benefit most from further research 
(ie, extra value of perfect information and extra value of 
partial perfect information analysis).38 39
Qualitative methods
A verbatim transcript of qualitative interviews will be 
made and entered into qualitative analysis software 
(NVIVO) and key themes coded using framework anal-
ysis.40 A sample of interviews will be analysed by two senior 
investigators to check levels of coding agreement with the 
template.
Public and patient involvement
The original research proposal was developed in collabo-
ration with UK Dementia and Neurodegenerative Diseases 
Network Patient and Public Involvement representatives 
(SN and BW-C), who are grant co-applicants. Two CRPs 
have been created to ensure public involvement at all 
stages, chaired by SN (London) and BW-C (Bradford). 
Each panel comprises up to eight family carers of people 
with dementia and a person living with dementia. The 
carers are members of, and supported by, the Alzheimer’s 
Society research volunteer network. They will meet at 
6-monthly intervals throughout the programme, advise 
and work collaboratively on recruitment and consent 
processes, accessibility of information leaflets, data collec-
tion, interpretation and dissemination. Our CRP chairs 
will attend study recruitment and information events 
at participating care homes to publicise the trial. They 
provide strategic oversight by attending programme 
steering group and international advisory meetings. We 
held informal consultations with a group of seven resi-
dents living in one nursing home to inform development 
of study information materials for residents.
Monitoring and trial management
Our intervention is low-risk and an enhancement of usual 
care. We will collect data on potential SAEs; those that 
may result in death, be life-threatening, require hospi-
talisation or prolongation of existing hospitalisation or 
result in persistent or significant disability or incapacity. 
These will be reported to the chief investigator and esca-
lated to the research ethics committee if they are unex-
pected and related to research procedures.
A trial management group meets monthly and includes 
individuals responsible for day-to-day study management. 
It will monitor all aspects of the conduct and progress of 
the study, ensuring adherence to the protocol and will 
take appropriate action to safeguard participants and 
trial quality. For this pilot trial, it also takes on the role of 
a data monitoring committee. The BHiRCH Programme 
Steering Committee includes senior members of the 
research team and external experts and supervises the 
overall programme, on behalf of NIHR and the Sponsor. 
An international advisory group provides advice and 
Data collected and tool used Pre-intervention Monthly
At 6 months 
only Post-intervention
  Deaths in the last calendar 
month
S S S S
  Staff turnover S S S S
  Care home occupancy level Number of available beds to new 
residents.
S S S S
CP, care partner; P, participant; R researcher; S, care home staff.
Table 1 Continued 
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guidance to ensure the project remains grounded in real 
experience and is informed by international best practice 
and research.
dIsCussIon
The aim of our study is to pilot test an intervention to 
reduce avoidable acute hospital admissions for the four 
most common ACSCs in UK nursing home residents. 
Our intervention is closely aligned with UK health policy 
which aims to improve healthcare provided within nursing 
homes and prevent distressing transitions to acute hospi-
tals. Despite policy imperatives, little empirical research 
has been conducted in this area in the UK. The quality of 
intervention studies has varied with insufficient attention 
paid to methodology, particularly implementation, inter-
vention adherence and clustering effects.
We have adapted elements of an existing intervention 
(INTERACT) to the UK context with stakeholder input 
and extensive co-design. Trials of complex interventions 
are often methodologically challenging but the nursing 
home environment brings additional issues. Each nursing 
home, even those that are part of large company chains, 
is unique in context, with a distinct culture of care and 
variability in practice which may be greater than that 
seen in clinical NHS settings. A particular strength of our 
intervention is that the implementation is informed by 
implementation science theory, tailored to the context 
and led by local PDCs supported by a local PDC support 
group comprised of key stakeholders who can assist with 
achieving change in care practice.
We anticipate participant recruitment, particularly of 
residents with impaired capacity to consent to research 
procedures may be challenging. Additionally, nursing 
homes may not have the infra-structure to support data 
collection . We plan to overcome these problems through 
developing the role of an existing member of the nursing 
home staff as a research facilitator and will provide reim-
bursement for their time and additional work.
Our pilot study will provide data to indicate whether a 
fully powered randomised controlled trial is warranted. 
In addition it will provide invaluable information on how 
to optimise the implementation of complex interventions 
in nursing homes.
EthICs And dIssEMInAtIon
Some residents may have dementia or other conditions 
that impair their ability to give informed consent to 
participate in the individual data collection, and we will 
adhere to the UK Mental Capacity Act (2005). We have 
an established procedure should we observe incidents of 
concern and will adhere to local authority safeguarding 
procedures.
Academic dissemination will be through publication 
of results, reported per CONSORT guidelines in interna-
tional peer-review journals and conference presentations. 
Regular updates will be given via social media, our website 
(https://www. brad. ac. uk/ health/ dementia/ research/ 
bhirch/) and twitter (@BHIRCHCareHomes). We will 
present at congresses attended by nursing home owners 
and staff and will hold a national conference at the end of 
the study to disseminate findings and share best practice 
on active care for ACSCs.
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